Therapeutic misalignment averted by clonal evolutionary evidence: molecular confirmation of hepatic metastasis in SMARCA4-deficient non-small cell lung cancer initially misdiagnosed as resectable cholangiocarcinoma
ObjectivesSMARCA4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) exhibits significant histomorphological diversity and intertumoral heterogeneity. Immunophenotypically, it often lacks lineage-specific markers, making diagnosis challenging, especially in cases of hepatic metastasis. Currently,...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-03-01
|
| Series: | Frontiers in Oncology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1743908/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
